AIM: The aim of the study was to assess current patterns of antibiotic prescribing and the impact of a hospital antibiotic policy on these practices. METHODS: The study involved collecting information regarding hospitalized patients utilizing the ESAC audit tool. RESULTS: In the study site hospital, the use of the restricted agents was low whilst the use of the non-restricted agents was high. Compliance with the hospital antibiotic guidelines was 70%. DISCUSSION: The findings identified monitoring non-restricted antibiotics and compliance with guidelines as targets for quality improvements in our hospital. Point prevalence surveys may offer a simple method of monitoring antibiotic policies, thus, informing antibiotic stewardship.
AIM: The aim of the study was to assess current patterns of antibiotic prescribing and the impact of a hospital antibiotic policy on these practices. METHODS: The study involved collecting information regarding hospitalized patients utilizing the ESAC audit tool. RESULTS: In the study site hospital, the use of the restricted agents was low whilst the use of the non-restricted agents was high. Compliance with the hospital antibiotic guidelines was 70%. DISCUSSION: The findings identified monitoring non-restricted antibiotics and compliance with guidelines as targets for quality improvements in our hospital. Point prevalence surveys may offer a simple method of monitoring antibiotic policies, thus, informing antibiotic stewardship.
Authors: Mamoon A Aldeyab; Stephan Harbarth; Nathalie Vernaz; Mary P Kearney; Michael G Scott; Chris Funston; Karen Savage; Denise Kelly; Motasem A Aldiab; James C McElnay Journal: Antimicrob Agents Chemother Date: 2009-03-16 Impact factor: 5.191
Authors: Mamoon A Aldeyab; Dominique L Monnet; José María López-Lozano; Carmel M Hughes; Michael G Scott; Mary P Kearney; Fidelma A Magee; James C McElnay Journal: J Antimicrob Chemother Date: 2008-05-07 Impact factor: 5.790
Authors: Mamoon A Aldeyab; Stephan Harbarth; Nathalie Vernaz; Mary P Kearney; Michael G Scott; Feras W Darwish Elhajji; Motasem A Aldiab; James C McElnay Journal: Br J Clin Pharmacol Date: 2012-07 Impact factor: 4.335
Authors: G M Al-Taani; M Scott; D Farren; F Gilmore; B Mccullagh; C Hibberd; A Mccorry; A Versporten; H Goossens; P Zarb; M A Aldeyab Journal: Epidemiol Infect Date: 2018-04-25 Impact factor: 4.434